Norsk Hydro: Status tilbakekjøp av egne aksjer
Nedenfor er informasjon om transaksjoner foretatt under tilbakekjøpsprogrammet for Norsk Hydro ASA.
Dato for når tilbakekjøpsprogrammet ble annonsert: 23. september 2022
Tilbakekjøpsprogrammets varighet: 29. mars 2023
Oversikt over transaksjoner:
| Dato | Aggregert daglig volum (antall aksjer) | Gjennomsnittpris (NOK) | Total transaksjonsverdi (NOK) |
| 17.01.2023 | 129 000 | 78,28 | 10 098 133 |
| 18.01.2023 | 122 000 | 81,55 | 9 949 588 |
| 19.01.2023 | 126 000 | 79,91 | 10 069 101 |
| 20.01.2023 | 125 000 | 80,36 | 10 044 563 |
| 23.01.2023 | 123 000 | 81,70 | 10 049 457 |
| Tidligere transaksjoner | 11 623 000 | ||
| Totalt offentliggjorte tilbakekjøp under programmet | 12 248 000 | 68,58 | 840 027 570 |
I forkant av tilbakekjøpsprogrammet eide Norsk Hydro totalt 16 452 403 egne aksjer. Etter gjennomføringen av overnevnte transaksjoner, eier Norsk Hydro ASA totalt 28 700 403 egne aksjer, tilsvarende 1,39% av Norsk Hydro ASAs aksjekapital.
Vedlegg: En oversikt over alle gjennomførte handler under tilbakekjøpsprogrammet som er uført i overnevnte tidsperiode er vedlagt denne meldingen og tilgjengelig på www.newsweb.no.
Denne opplysningen er informasjonspliktig i henhold til EUs Market Abuse Regulation og krav i henhold til den norske verdipapirhandelloven § 5-12.
Investorkontakt:
Line Haugetraa
Head of Investor Relations
+47 41406376
Line.haugetraa@hydro.com
Vedlegg
Hvis du vil se dette innholdet fra www.globenewswire.com, gi ditt samtykke øverst på denne siden.Hvis du vil se dette innholdet fra ml-eu.globenewswire.com, gi ditt samtykke øverst på denne siden.
Om GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg pressemeldinger fra GlobeNewswire by notified
Registrer deg med din e-postadresse under for å få de nyeste sakene fra GlobeNewswire by notified på e-post fortløpende. Du kan melde deg av når som helst.
Siste pressemeldinger fra GlobeNewswire by notified
Subsea7 share repurchases6.5.2024 08:00:00 CEST | Press release
Luxembourg – 6 May 2024 - Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced transactions made in accordance with its share repurchase programme during the week commencing 29 Apr 2024. Date on which the share repurchase programme was announced: 25 July 2019, with a two-year extension announced on 19 April 2023. The duration of the share repurchase programme: until 18 April 2025. In the period from 29 April 2024 until 3 May 2024 Subsea 7 S.A. has repurchased a total of 117,434 own shares at the Oslo Stock Exchange at an average price of NOK 181.9519 per share. Overview of transactions Dates Aggregated daily volume (number of shares) Weighted average share price per day (NOK) Total daily transaction value (NOK) 29 April 2024 - - - 30 April 2024 - - - 01 May 2024 - - - 02 May 2024 58,434 182.0130 10,635,748 03 May 2024 59,000 181.8914 10,731,593 Previously disclosed 10,971,778 77.6346 851,789,527 Accumulated 11,089,212 78.7393 873,156,867 The issuer’s holding of own shares: Follo
One hundred compact SATO homes became available for rent in Leppävaara, Espoo6.5.2024 08:00:00 CEST | Press release
SATO Corporation, Press release 6 May 2024 at 9:00 am In Leppävaara, Espoo, 100 rental apartments have just become available in SATO's unique building. The apartments are compact in size and the competitive rental level makes these homes accessible to many. Several cleverly sized SATOhomes in Vallikallio, Espoo’s Leppävaara district, were released for rent in April. The majority of the rental apartments in the unique building on Porarinkatu 3 are studios smaller than 30 square meters, making them particularly suitable for young individuals looking for their first own home, as well as for students, workers relocating from other areas needing a secondary residence, or seasonal workers needing a place to live. These small and reasonably priced apartments are also suitable as temporary homes, for example during pipe repairs. The building with one hundred apartments is conveniently located near Leppävaara train station and the light rail stop, with good public transport connections. There i
Fingerprints and Infrafon collaborating on new smart badges for the European Medical and IoT market6.5.2024 08:00:00 CEST | Press release
Fingerprint Cards AB (Fingerprints™) and Infrafon, a German based biometric wearables technology startup, are collaborating to develop and launch biometric smart badge products for the European market. The Infrafon SmartBadge CC1-SEC, developed by the Freiburg-based company offers MultiFactor Authentication including a biometric solution based on Fingerprints’ biometric sensors, software and algorithm benefitting from leading performance, and the company’s years of experience in secure biometrics innovation. The innovative smart badge from Infrafon supports both physical and logical access including FIDO2 and eIDAS, providing a zero-trust environment with a convenient biometric verification for the users. Infrafon founder Frieder Hansen comments: “Infrafon Smart badge is a new type of device between SmartCard and Smartphone where a connected Smart Badge allows both visual and eID. It is used to access NFC or Bluetooth operated doors, devices and access to PCs. It also helps organizatio
Health Canada Approves Nexstim NBS 6 System for Treatment of MDD6.5.2024 08:00:00 CEST | Press release
Press release, Helsinki, 6 May 2024 at 9 AM (EEST) Health Canada Approves Nexstim NBS 6 System for Treatment of MDD Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received approval from Health Canada for the marketing and commercial distribution of its NBS 6 system for the treatment of Major Depressive Disorder (MDD). Released in the EU and the United States in 2023, the NBS 6 is a new generation Nexstim system. The NBS 6 is currently FDA-approved for the treatment of major depressive disorder (MDD), and CE marked for the treatment of major depression and chronic neuropathic pain. One of the unique features of the NBS 6 is its modular design that allows for expansions of system capabilities over time. Mikko Karvinen, CEO of Nexstim, comments: “We have been happy with the progress made with the release of the NBS 6, and this Health Canada approval gets us one step further on our commercial expansion journey. We continue to be actively present in the Canadian market, working closel
Corbion reports the progress of its € 20 million share buyback program 29 April – 3 May 20246.5.2024 07:00:00 CEST | Press release
Corbion hereby reports the transaction details related to its € 20 million share buyback program announced on 26 April 2024. During the week of 29 April up to and including 3 May 2024 a total of 38,702 shares were repurchased at an average price of €20.5887 for a total amount of €796,825.79. To date, the total consideration for shares repurchased amounts to €796,825.79 representing 3.98% of the overall share buyback program. Corbion publishes on a weekly basis every Monday, an overview of the progress of the share buyback program on its website: https://www.corbion.com/Investor-relations/shareholder-information This overview contains detailed information on the daily amount of repurchased shares and individual share purchase transactions. Attachment Weekly progress on Corbion share buyback program 29 April – 3 May 2024